| 翻訳と辞書 |
| Øyvind S. Bruland ： ウィキペディア英語版 |
Øyvind S. Bruland
Øyvind S. Bruland (born 1952) is a professor of Clinical Oncology and faculty of Medicine at the University of Oslo. Bruland holds a B.Sc., M.D and Ph.D. from the University of Oslo, Norway. His research includes: primary bone and soft tissue cancers (sarcomas) and skeletal metastases from prostate cancer and breast cancer; targeted radionuclide therapy, for instance the clinical development of Alpharadin, based on Radium-223; the tumor biology and prognostic impact of micro-metastases in bone-marrow aspirates on patients with primary bone cancer (osteosarcoma); external beam radiotherapy; and the radiotherapy of skeletal metastases and soft-tissue sarcomas.
He has served as supervisor to twelve Ph.D students, nine so far having completed their Ph.D. theses. In 2008 he was elected as a member of the Norwegian Academy of Science and Letters.
== References ==
*(Alpharadin trial treatment of cancer with skeletal metastasis )
*(Lancet publication of Alpaharadin phase II results )
*(US Approval for phase III testing of Alpharadin )
*(US National Institute of Health information on Alpharadin )
*(Publications according to PubMed )
*(Øyvind S. Bruland, further information )
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「Øyvind S. Bruland」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|